Tianjin Ringpu Bio Tech (300119) — Net Asset Quality Index
Tianjin Ringpu Bio Tech (300119) has a Net Asset Quality Index of 67.6% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥7.80 Billion minus total liabilities of CN¥2.53 Billion yields net assets of CN¥5.27 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Read 300119 liabilities breakdown for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Tianjin Ringpu Bio Tech Net Asset Quality Index Over Time (2007–2025)
This chart shows how Tianjin Ringpu Bio Tech's Net Asset Quality Index has evolved across 19 annual periods from 2007 to 2025. As of March 2026, the index stands at 67.6%, representing net assets of CN¥5.27 Billion against total assets of CN¥7.80 Billion CNY. For live market cap and overall valuation, see 300119 market cap overview.
Annual Net Asset Quality Index for Tianjin Ringpu Bio Tech (2007–2025)
The table below presents the year-by-year Net Asset Quality Index for Tianjin Ringpu Bio Tech from 2007 to 2025, covering 19 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check Tianjin Ringpu Bio Tech (300119) strategic asset index to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 67.7% | CN¥5.18 Billion | CN¥7.66 Billion | CN¥2.47 Billion | ▲ +4.9 pp |
| 2024 | 62.9% | CN¥5.01 Billion | CN¥7.97 Billion | CN¥2.96 Billion | ▼ -10.0 pp |
| 2023 | 72.8% | CN¥4.80 Billion | CN¥6.60 Billion | CN¥1.79 Billion | ▼ -0.9 pp |
| 2022 | 73.7% | CN¥4.50 Billion | CN¥6.11 Billion | CN¥1.61 Billion | ▼ -2.3 pp |
| 2021 | 76.0% | CN¥4.32 Billion | CN¥5.69 Billion | CN¥1.37 Billion | ▲ +5.8 pp |
| 2020 | 70.2% | CN¥2.74 Billion | CN¥3.90 Billion | CN¥1.16 Billion | ▲ +4.0 pp |
| 2019 | 66.2% | CN¥2.36 Billion | CN¥3.56 Billion | CN¥1.21 Billion | ▼ -9.0 pp |
| 2018 | 75.2% | CN¥2.25 Billion | CN¥3.00 Billion | CN¥744.03 Million | ▲ +0.8 pp |
| 2017 | 74.4% | CN¥2.18 Billion | CN¥2.92 Billion | CN¥747.95 Million | ▼ -2.6 pp |
| 2016 | 77.0% | CN¥2.11 Billion | CN¥2.73 Billion | CN¥627.74 Million | ▲ +1.7 pp |
| 2015 | 75.3% | CN¥1.77 Billion | CN¥2.35 Billion | CN¥579.77 Million | ▼ -11.7 pp |
| 2014 | 87.0% | CN¥1.73 Billion | CN¥1.98 Billion | CN¥257.23 Million | ▲ +1.2 pp |
| 2013 | 85.9% | CN¥1.72 Billion | CN¥2.00 Billion | CN¥282.89 Million | ▼ -2.6 pp |
| 2012 | 88.5% | CN¥1.59 Billion | CN¥1.79 Billion | CN¥206.99 Million | ▼ -1.1 pp |
| 2011 | 89.5% | CN¥1.50 Billion | CN¥1.67 Billion | CN¥175.12 Million | ▲ +1.6 pp |
| 2010 | 87.9% | CN¥1.43 Billion | CN¥1.62 Billion | CN¥195.66 Million | ▲ +27.1 pp |
| 2009 | 60.8% | CN¥252.48 Million | CN¥415.11 Million | CN¥162.63 Million | ▼ -13.8 pp |
| 2008 | 74.6% | CN¥249.97 Million | CN¥335.15 Million | CN¥85.18 Million | ▲ +1.5 pp |
| 2007 | 73.0% | CN¥136.21 Million | CN¥186.46 Million | CN¥50.26 Million | — |